These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1915379)

  • 21. Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin.
    Bultmann H; Santas AJ; Peters DM
    J Biol Chem; 1998 Jan; 273(5):2601-9. PubMed ID: 9446562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix.
    McDonald JA; Quade BJ; Broekelmann TJ; LaChance R; Forsman K; Hasegawa E; Akiyama S
    J Biol Chem; 1987 Mar; 262(7):2957-67. PubMed ID: 3818629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of extracellular fibronectin matrix formation with fluoresceinated fibronectin and fibronectin fragments.
    Chernousov MA; Metsis ML; Koteliansky VE
    FEBS Lett; 1985 Apr; 183(2):365-9. PubMed ID: 3921405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model of fibronectin tertiary structure based on studies of interactions between fragments.
    Homandberg GA; Erickson JW
    Biochemistry; 1986 Nov; 25(22):6917-25. PubMed ID: 3801402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities.
    McCarthy JB; Chelberg MK; Mickelson DJ; Furcht LT
    Biochemistry; 1988 Feb; 27(4):1380-8. PubMed ID: 2966638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it.
    Salonen EM; Jauhiainen M; Zardi L; Vaheri A; Ehnholm C
    EMBO J; 1989 Dec; 8(13):4035-40. PubMed ID: 2531657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrophobic properties of porcine fibronectin and its functional domains.
    Hayashi-Nagai A; Kitagaki-Ogawa H; Matsumoto I; Hayashi M; Seno N
    J Biochem; 1991 Jan; 109(1):83-8. PubMed ID: 2016277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel synthetic peptides from the C-terminal heparin binding domain of fibronectin with heparin binding activity.
    Mohri H; Katoh K; Motomura S; Okubo T
    Peptides; 1996; 17(6):1079-81. PubMed ID: 8899830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibody against the N-terminal end of human plasma fibronectin.
    Vartio T; Salonen EM; De Petro G; Barlati S; Miggiano V; Stähli C; Virgallita G; Takács B; Vaheri A
    Biochem J; 1983 Oct; 215(1):147-51. PubMed ID: 6194791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary structure of human plasma fibronectin. Characterization of a 31,000-dalton fragment from the COOH-terminal region containing a free sulfhydryl group and a fibrin-binding site.
    Garcia-Pardo A; Pearlstein E; Frangione B
    J Biol Chem; 1985 Aug; 260(18):10320-5. PubMed ID: 4019516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that binding to the carboxyl-terminal heparin-binding domain (Hep II) dominates the interaction between plasma fibronectin and heparin.
    Benecky MJ; Kolvenbach CG; Amrani DL; Mosesson MW
    Biochemistry; 1988 Sep; 27(19):7565-71. PubMed ID: 3207688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple binding sites in fibronectin and the staphylococcal fibronectin receptor.
    Bozzini S; Visai L; Pignatti P; Petersen TE; Speziale P
    Eur J Biochem; 1992 Jul; 207(1):327-33. PubMed ID: 1385780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of collagenase/gelatinase activity from basement-membrane fibronectin--isolation after limited proteolysis of a bovine lens capsule and molecular definition of this thiol-dependent zinc metalloproteinase.
    Boudjennah L; Dalet-Fumeron V; Pagano M
    Eur J Biochem; 1998 Jul; 255(1):246-54. PubMed ID: 9692925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a Fusobacterium nucleatum 65 kDa serine protease.
    Bachrach G; Rosen G; Bellalou M; Naor R; Sela MN
    Oral Microbiol Immunol; 2004 Jun; 19(3):155-9. PubMed ID: 15107066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fibronectin-binding domain of transglutaminase.
    Jeong JM; Murthy SN; Radek JT; Lorand L
    J Biol Chem; 1995 Mar; 270(10):5654-8. PubMed ID: 7890687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneity.
    Garcia-Pardo A; Rostagno A; Frangione B
    Biochem J; 1987 Feb; 241(3):923-8. PubMed ID: 3593230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of the active site of m-calpain and the interaction with calpastatin.
    Crawford C; Brown NR; Willis AC
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):135-42. PubMed ID: 8250833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 31-kDa recombinant fibronectin cell-binding domain fragment: its binding to receptor, cell adhesive activity, and fusion proteins.
    Hashino K; Uemori Y; Kimizuka F; Kato I; Titani K
    J Biochem; 1996 Apr; 119(4):604-9. PubMed ID: 8743558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain.
    Pande H; Calaycay J; Lee TD; Legesse K; Shively JE; Siri A; Borsi L; Zardi L
    Eur J Biochem; 1987 Jan; 162(2):403-11. PubMed ID: 3803394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.